Incidence of Fragility Fractures and Osteoporosis Screening in Chronic Stroke Patients

Condition(s) studied

Study summary

Stroke is a known risk factor for the development of osteoporosis, leading to an increased risk of falls and fractures. Several international studies have associated stroke with hip fractures, showing an odds ratio ranging between 1.5 and 4. The literature frequently indicates a lack of management for bone metabolism in patients following cerebrovascular events. This study aims to evaluate the incidence of osteoporosis and fragility fractures in patients with chronic stroke. A secondary aim is to assess whether patients have been adequately screened for bone metabolism following a cerebrovascular event. This study is designed as a prospective observational study. Patients aged over 65 years with chronic stroke are assessed at the U.O.C. of "Functional Recovery and Rehabilitation" at A.O.U.P. "P. Giaccone," Palermo. During the assessment, clinical and demographic data are collected, including details of the cerebrovascular event (location, hemorrhagic/ischemic, date), pre-event and post-event disability/autonomy (Rankin scale), presence of fractures (location and date) in the patient's medical history (pre and post-event), femoral and lumbar DEXA for osteoporosis evaluation, and DeFRA for assessing the 10-year risk of fragility fractures.

Eligibility

Primary outcome measure(s)

• Evaluating the Incidence of Osteoporosis and Fragility Fractures in Chronic Stroke Patients — From enrollment to the end of treatment at 6 months
  The primary objective of this study is to evaluate the incidence of osteoporosis and fragility fractures in patients with chronic stroke.

Trial sites (1)

More University of Palermo trials in Italy

Other trials for the same condition